Cargando…
Dual therapy based on raltegravir and boosted protease inhibitors – the experience of Polish centers
INTRODUCTION: The aim of the study was to present the experience of Polish centers regarding dual therapy based on the integrase inhibitor raltegravir (RAL) and ritonavir-boosted protease inhibitors (PI/r) for treating treatment-naïve and -experienced HIV-infected patients. MATERIAL AND METHODS: The...
Autores principales: | Jabłonowska, Elżbieta, Pulik, Piotr, Kalinowska, Anna, Gąsiorowski, Jacek, Parczewski, Miłosz, Bociąga-Jasik, Monika, Mularska, Elżbieta, Pulik, Łukasz, Siwak, Ewa, Wójcik, Kamila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040130/ https://www.ncbi.nlm.nih.gov/pubmed/30002705 http://dx.doi.org/10.5114/aoms.2016.62445 |
Ejemplares similares
-
Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients
por: Jabłonowska, Elżbieta, et al.
Publicado: (2019) -
Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland
por: Kowalska, Justyna D., et al.
Publicado: (2022) -
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics
por: Parczewski, Milosz, et al.
Publicado: (2017) -
Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients
por: Kowalska, Justyna D., et al.
Publicado: (2016) -
Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland
por: Parczewski, Miłosz, et al.
Publicado: (2017)